Catapres and Zaroxolyn drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Catapres (clonidine hydrochloride) and Zaroxolyn (metolazone). Common drug interactions include rash among females and pain among males.

The phase IV clinical study analyzes what interactions people have when they take Catapres and Zaroxolyn. It is created by eHealthMe based on reports of 82 people who take the same drugs from the FDA, and is updated regularly.

What is Catapres?

Catapres has active ingredients of clonidine hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 6,680 Catapres users. Check the latest studies of Catapres.

What is Zaroxolyn?

Zaroxolyn has active ingredients of metolazone. It is often used in high blood pressure. eHealthMe is studying from 5,244 Zaroxolyn users. Check the latest studies of Zaroxolyn.



On Jul, 18, 2026

82 people who take Catapres and Zaroxolyn together, and have interactions are studied.

Catapres and Zaroxolyn drug interactions.

What are the common drug interactions of Catapres and Zaroxolyn, by gender? *:

female:

  1. Rash
  2. Vomiting
  3. Cardiomegaly (increased size of heart than normal)
  4. Dysphagia (a condition in which swallowing is difficult or painful)
  5. Hypotension (abnormally low blood pressure)
  6. Muscle spasms (muscle contraction)
  7. Oedema peripheral (superficial swelling)
  8. Abdominal pain
  9. Cardiac failure congestive
  10. Dehydration (dryness resulting from the removal of water)

male:

  1. Pain
  2. Pneumonia
  3. Coronary artery stenosis (narrowing of coronary artery)
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  5. Renal failure (kidney dysfunction)
  6. Renal failure chronic (long lasting kidney dysfunction)
  7. Ventricular fibrillation (abnormally irregular heart rhythm)
  8. Headache (pain in head)
  9. Cardiomyopathy (weakening of the heart muscle)
  10. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)

What are the common drug interactions of Catapres and Zaroxolyn, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Pneumonia
  2. Pulmonary toxicity (side effects on the lungs)
  3. Respiratory failure (inadequate gas exchange by the respiratory system)
  4. Thrombocytopenia (decrease of platelets in blood)
  5. Drug hypersensitivity
  6. Hypotension (abnormally low blood pressure)
  7. Abdominal pain upper
  8. Acne (skin problems that cause pimples)
  9. Acute respiratory failure
  10. Decreased appetite

30-39:

  1. Anaemia (lack of blood)
  2. Anxiety
  3. Asthenia (weakness)
  4. Cardiomegaly (increased size of heart than normal)
  5. Chest discomfort
  6. Chest pain
  7. Dizziness
  8. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
  9. Heart transplant
  10. Hyperkalaemia (damage to or disease of the kidney)

40-49:

  1. Cardiac failure congestive
  2. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  3. Pain
  4. Pneumonia
  5. Abdominal pain
  6. Acne (skin problems that cause pimples)
  7. Acute respiratory failure
  8. Adult respiratory distress syndrome (type of lung (pulmonary) failure)
  9. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
  10. Anxiety

50-59:

  1. Pneumonia
  2. Acute respiratory failure
  3. Hyperlipidaemia (presence of excess lipids in the blood)
  4. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  5. Cardiac failure congestive
  6. Cellulitis (infection under the skin)
  7. Constipation
  8. Coronary artery stenosis (narrowing of coronary artery)
  9. Ventricular fibrillation (abnormally irregular heart rhythm)
  10. Weight increased

60+:

  1. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  2. Pain
  3. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  4. Skin discolouration (change of skin colour)
  5. Skin hypertrophy (skin cells enlarges)
  6. Skin tightness
  7. Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding)
  8. Alopecia (absence of hair from areas of the body)
  9. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  10. Anhedonia (inability to experience pleasure from activities usually found enjoyable)

What are the existing conditions these people have? *

  1. Diabetes: 11 people, 13.41%
  2. Cardiac Disorder: 9 people, 10.98%
  3. Nuclear Magnetic Resonance Imaging Brain: 6 people, 7.32%
  4. High Blood Cholesterol: 6 people, 7.32%
  5. Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 6 people, 7.32%
  6. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 7.32%
  7. Pain: 5 people, 6.10%

* Approximation only. Some reports may have incomplete information.

Do you take Catapres and Zaroxolyn?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Catapres and Zaroxolyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Catapres:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zaroxolyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Catapres and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zaroxolyn and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on clonidine hydrochloride and metolazone (the active ingredients of Catapres and Zaroxolyn, respectively), and Catapres and Zaroxolyn (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: